What is FlexBiosys?
FlexBiosys, operating under the umbrella of BioFlex Solutions and recognized as a Repligen company, is a specialized manufacturer of single-use bioprocessing products. Their offerings include custom-designed bags, bottles, and tubing assemblies, produced within an ISO Class 7 certified cleanroom in San José. With a design team boasting over 35 years of experience and adherence to ISO 9001:2015, ISO 13485:2016, and cGMP standards, FlexBiosys is committed to high-quality production for the biopharmaceutical sector. The company's focus on tailored solutions addresses diverse and critical bioprocessing needs.
How much funding has FlexBiosys raised?
FlexBiosys has raised a total of $334K across 2 funding rounds:
Debt
$150K
Debt
$184K
Debt (2020): $150K with participation from PPP
Debt (2021): $184K led by PPP
Key Investors in FlexBiosys
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for FlexBiosys?
The substantial capital infusion, particularly the recent strategic investment, positions FlexBiosys for accelerated growth and enhanced market penetration. This funding is expected to fuel advancements in their product development, expand manufacturing capabilities, and potentially broaden their reach within the global biopharmaceutical supply chain. The company's late-stage funding context suggests a focus on optimizing operations, scaling production to meet increasing demand, and solidifying its competitive advantage through continued innovation and strategic partnerships.
See full FlexBiosys company page
